About IntriCon

Philip Smith became a director in April 2016 and Chairman in May 2019. Mr. Smith has served as a managing director at the investment banking firm, Duff & Phelps beginning in March 2017, where he focuses on the healthcare industry. Prior to that, Mr. Smith was a managing director with the investment banking firm, BMO Capital Markets (formerly Greene Holcomb Fisher). Prior to joining Greene Holcomb Fisher in 2011, Mr. Smith was President and Chief Executive Officer of Angeion Corporation, now MGC Diagnostics, a global medical technology company. Earlier experiences include being CEO of DGIMED Ortho, Executive Vice President of Business Development at Vital Images, and a healthcare investment banker at Piper Jaffray.

Mr. Giordano became a director in December 2000 and currently serves as the Chairman of the Audit Committee. Mr. Giordano has been a business consultant and investor since 1997. Mr. Giordano was Interim President of LaSalle University from July 1998 to June 1999. From 1981 to 1997, Mr. Giordano was President and Chief Executive Officer of the Philadelphia Stock Exchange. Mr. Giordano serves as a trustee of W.T. Trust and Kalmar Pooled Investment Trust, mutual funds, and as a director of Independence Blue Cross of Philadelphia, a health insurance company, and The RBB Fund, Inc., a mutual funds company.

Mr. Gorder has served as the President and Chief Executive Officer of IntriCon since April 2001 and a director since 1996. Previously he served as the Company's President and Chief Operating Officer from December 2000 to April 2001; and Vice President from 1996 to December 2000. Mr. Gorder was a founder, President and Chief Executive Officer of a predecessor company to IntriCon, which began operations in 1977 until its acquisition by the Company in 1993.

Mr. Huggenberger became a director in May 2019. He currently serves on the boards of publicly traded medical device companies Inogen Inc. (INGN) and Tactile Systems Technology Inc. (TCMD), as well as privately held medical device companies Sommetrics, Inc., Clarify Medical Inc. and Ebb Therapeutics, and Wellfount Corporation, a pharmacy services company. Mr. Huggenberger previously served on the board of IYIA Technologies, a healthcare company. Mr. Huggenberger previously was Inogen's President and Chief Executive Officer. Prior to joining Inogen in 2008, he held various management positions with Sunrise Medical Inc., a global manufacturer and distributor of durable medical equipment, culminating as its President and Chief Operating Officer.

Mr. Masucci became a director in February 2002. He has served as the Chairman of the Board of Montgomery Capital Advisors, Inc., a consulting company, since 1990 and Chairman of the Board of Barclay Brand Ferdon, Inc., a distribution company, since 1996. Prior to 1990, Mr. Masucci was President and Chief Executive Officer of Drexel Industries, Inc., a forklift manufacturer.

Heather Rider has served as a Member of our Board and Chairperson of the Compensation Committee since March 2020. Ms. Rider's experience includes more than 30 years as a leader in global human resources for the medical technology industry. She is currently a Director of Inogen Inc. and serves as Chair, Compensation, Nominating and Governance Committee. Her career includes executive level positions with medical device companies such as Intuitive Surgical, Inc. and Alphatec Spine, Inc. She also served in leadership roles in the human resources organizations of Sunrise Medical and Biosense Webster, a member of the J & J family of companies. Most recently, Ms. Rider was vice president of global human resources for Cymer, Inc., the leader in developing light sources used by chipmakers worldwide to pattern advanced semiconductor chips. Ms. Rider holds a Bachelor of Arts in Psychology from Claremont.